Superworth

Large drugmakers with the lowest PE ratio

Share price divided by earnings per share over the last twelve months. As of .

Ranked
41
of 411 large drugmakers we cover
Median
19.1×
Lowest
2.5×
CRMD
Range
2.5× to 192×
median 19.1×
2.5×192×
#CompanyPEPE vs its 10 yearsRevenue growth (TTM)Market cap
1CRMDCorMedix2.5×0th pct+280.5%$420.1M
2ATNMActinium Pharmaceuticals4.0×n/an/m$45M
3IRWDIronwood Pharmaceuticals4.5×0th pct+26.2%$571.7M
4ABUSArbutus Biopharma5.1×n/an/m$791.4M
5SPROSpero Therapeutics9.5×48th pct−3.3%$60.6M
6INDVIndivior Pharmaceuticals10.2×2nd pct+16.3%$4.3B
7ANABAnaptysbio10.3×n/an/m$1.4B
8ZVRAZevra Therapeutics10.9×n/a+119.4%$599.8M
9NRIXNurix Therapeutics11.1×n/an/m$2.8B
10OMEROmeros11.7×n/an/m$1.3B
11NATRNatures Sunshine Products11.9×5th pct+6.8%$211.5M
12HRMYHarmony Biosciences12.3×30th pct+24.3%$2.2B
13PBHPrestige Consumer Healthcare13.9×32nd pct−1.4%$2.4B
14BMYBristol-Myers Squibb14.0×12th pct+4.2%$128.7B
15JAZZJazz Pharmaceuticals14.7×16th pct+12.6%$13.9B
16LFVNLifevantage14.7×31st pct−20.1%$73.5M
17ANIPANI Pharmaceuticals15.0×0th pct+30.9%$1.6B
18PAHCPhibro Animal Health15.9×19th pct+17.1%$1.6B
19AMPHAmphastar Pharmaceuticals15.9×31st pct+1.0%$1.1B
20OGNOrganon18.2×99th pct−3.2%$3.6B
21COLLCollegium Pharmaceutical19.1×50th pct+14.3%$770.9M
22PBYIPuma Biotechnology19.6×76th pct−2.9%$525.5M
23TGTXTG Therapeutics21.9×65th pct+76.1%$9.2B
24AMGNAmgen29.0×80th pct+9.1%$252.3B
25LQDALiquidia30.1×n/an/m$3.7B
26LGNDLigand Pharmaceuticals32.7×41st pct+54.9%$6.1B
27PFEPfizer40.6×98th pct−0.2%$176B
28JNJJohnson & Johnson40.9×90th pct+7.8%$650.2B
29AMRXAmneal Pharmaceuticals41.7×33rd pct+9.3%$6.5B
30BIIBBiogen44.3×99th pct+0.3%$37B
31LLYEli Lilly and46.5×55th pct+45.5%$1.3T
32ARVNArvinas47.0×n/a−15.0%$491.7M
33ABBVAbbVie49.8×74th pct+10.7%$511.6B
34KNSAKiniksa Pharmaceuticals International93.6×59th pct+58.9%$7.1B
35PCRXPacira BioSciences104×68th pct+5.7%$1.5B
36ALKSAlkermes plc.118×95th pct+10.8%$7.5B
37PTGXProtagonist Therapeutics135×81st pct+34.8%$9B
38ARQTArcutis Biotherapeutics142×n/a+76.1%$3.9B
39MRKMerck150×100th pct+4.9%$359.5B
40BMRNBiomarin Pharmaceutical155×70th pct+11.2%$11.1B
41CORTCorcept Therapeutics192×93rd pct+16.0%$8.7B

Not ranked: 289 with a loss over the last year, 20 with a quarter missing, 11 with not a meaningful number. 50 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

PE for other groups

Other rankings of large drugmakers

The group